Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells

Biological Procedures Online, Sep 2017

Background Immunotherapy is a very fast expanding field within drug discovery and, hence, rapid and inexpensive expression of antibodies would be extremely valuable. Antibodies are, however, difficult to express. Multifunctional antibodies with additional binding domains further complicate the expression. Only few protocols describe the production of tetravalent bispecific antibodies and all with limited expression levels. Methods Here, we describe a protocol that can produce functional tetravalent, bispecific antibodies at around 22 mg protein/l to a low cost. The expression system is based on the Expi293 cells, which have been adapted to grow in denser cultures than HEK293 cells and gives higher expression yields. The new protocol transfects the Expi293 cells with PEI (which has a negligible cost). Results The protocol has been used to generate multiple variants of tetra- and hexavalent bispecific antibodies with yields of around 22 mg protein/l within 10 days. All materials are commercially available and the implementation of the protocol is inexpensive and straightforward. The bispecific antibodies generated in our lab were capable of binding to all antigens with similar affinity as the original antibody. Two of the bispecific antibodies have also been used in transgenic mice as positron emission tomography (PET) ligands to successfully detect amyloid-beta (Aβ) aggregates in vivo. Conclusions This protocol is the first describing transfection of the human Expi293 cells with PEI. It can be used to generate functional multi-specific antibodies in high amounts. The use of biological drugs, and in particular multispecific antibodies, is rapidly increasing, hence improved protocols such as the one presented here are highly valuable.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1186%2Fs12575-017-0060-7.pdf

Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells

Fang et al. Biological Procedures Online Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells Xiaotian T. Fang 1 Dag Sehlin 1 Lars Lannfelt 1 Stina Syvänen 1 Greta Hultqvist 0 1 0 Department of Pharmaceutical biosciences, Uppsala University, Biomedical center , Husargatan 3, Box 591, 75124 Uppsala , Sweden 1 Department of Public Health and Caring Sciences, Uppsala University, Rudbeck laboratory , Dag Hammarskjöldsväg 20, 751 85 Uppsala , Sweden Background: Immunotherapy is a very fast expanding field within drug discovery and, hence, rapid and inexpensive expression of antibodies would be extremely valuable. Antibodies are, however, difficult to express. Multifunctional antibodies with additional binding domains further complicate the expression. Only few protocols describe the production of tetravalent bispecific antibodies and all with limited expression levels. Methods: Here, we describe a protocol that can produce functional tetravalent, bispecific antibodies at around 22 mg protein/l to a low cost. The expression system is based on the Expi293 cells, which have been adapted to grow in denser cultures than HEK293 cells and gives higher expression yields. The new protocol transfects the Expi293 cells with PEI (which has a negligible cost). Results: The protocol has been used to generate multiple variants of tetra- and hexavalent bispecific antibodies with yields of around 22 mg protein/l within 10 days. All materials are commercially available and the implementation of the protocol is inexpensive and straightforward. The bispecific antibodies generated in our lab were capable of binding to all antigens with similar affinity as the original antibody. Two of the bispecific antibodies have also been used in transgenic mice as positron emission tomography (PET) ligands to successfully detect amyloid-beta (Aβ) aggregates in vivo. Conclusions: This protocol is the first describing transfection of the human Expi293 cells with PEI. It can be used to generate functional multi-specific antibodies in high amounts. The use of biological drugs, and in particular multispecific antibodies, is rapidly increasing, hence improved protocols such as the one presented here are highly valuable. Bispecific antibodies; Expi293; HEK293; PEI; Transient protein expression Background Immunotherapy is today a very fast advancing fields within drug discovery. Efforts are being made to develop antibodies that can be used to treat a large number of different diseases. With the recent advances in multifunctional antibody design the possibilities have increased even further. For efficient testing of potential drug candidates, it is essential to have a fast and inexpensive system to express many different antibodies. However, antibodies are difficult to expresses due to their large size. Furthermore, the two heavy and two light chains need to be paired correctly. Multispecific antibodies with additional binding domains, e.g. tetravalent bispecific antibodies (Fig. 1), further complicate the expression. For many applications, post-translational modifications are essential and hence an expression system as similar to the human body as possible is desired. Traditionally, stable cell lines expressing antibodies were a necessity to generate sufficient amounts of the antibody, even for validation experiments. However, there has been a lot of progress in the last decade in transient expression of recombinant proteins. For instance, the robust and easily transfected HEK293 cell line has been adapted to growth in suspension [ 1 ]. Furthermore, it has been discovered that addition of cell cycle inhibiting substances after the transfection step will increase the protein yield [ 2, 3 ]. Promoters such as CMW and SV40 and other regulatory elements have been improved [4]. Alternative transfection techniques have been discovered and upgraded. It was shown that polyethylenimine (PEI) can be used to transfect HEK293 cells [ 5 ]. Most of the protocols for the production of recombinant proteins at high yields are based on the HEK293EBNA1-6E cell line that expresses a truncated version of the Epstein–Barr nuclear antigen 1 (EBNA1), which increases protein expression [ 6, 7 ]. However, this cell line is not commercially available anymore and patents restrict its commercial use. There are only a few protocols describing the purification of tetravalent bispecific antibodies and these methods have only achieved limited expression levels [ 8–10 ]. Here, we describe an expression protocol that uses only commercially available materials and in a 10day process can produce functional tetravalent, bispecific antibodies at 22 mg protein per liter culture to a low cost. See Fig. 2 for a schematic overview. The expression system is based on the Expi293 cells (LifeTechnologies), that have been adapted to grow in denser cultures than normal HEK293 cells (the adapted cells are healthy at 5 million cells (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1186%2Fs12575-017-0060-7.pdf

Xiaotian T. Fang, Dag Sehlin, Lars Lannfelt, Stina Syvänen, Greta Hultqvist. Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells, Biological Procedures Online, 2017, pp. 11, Volume 19, Issue 1, DOI: 10.1186/s12575-017-0060-7